States are asking for about $ 26.4 billion from major players in pharmaceutical industry to help pay for damages caused by the opioid crisis, people familiar with the matter said, the latest question in years of litigation that companies are trying to responsible for widespread drug addiction. The current talks …
Read More »Sanofi Buys Principia for $ 3.7 billion. Both front runs.
Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …
Read More »The ‘excessive deaths’ in the US are 204,691 in 7 months – so COVID-19 deaths may be too bad
The death toll in the United States through July 2020 is 8% to 12% higher than it would have been if the coronavirus pandemic had never happened. That is at least 164,937 deaths above the number expected for the first seven months of the year – 16,183 more than the …
Read More »COVID-19 fax maker CureVac nearly triples Nasdaq debut
Shares of German biotechnology company CureVac nearly third in their Nasdaq debut Friday, marking the first stock market debut of a company developing a potential vaccine to combat the new coronavirus. The stock opened at $ 44 per share, up from the initial public offering price of $ 16 per …
Read More »News updates: McKesson Stock jumps after Trump says company would spread Coronavirus vaccine
(Photo by Joe Raedle / Getty Images) Getty Images Text size Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • President Donald Trump said Friday that McKesson would work with the U.S. government to spread a coronavirus vaccine if one is approved. …
Read More »